CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 35 enrolled
Drug / intervention
WATCHMAN Left Atrial Appendage Closuredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03040622
NCT03040622N/ACompleted
CompareCT.gov

The Evaluation of Thrombogenicity in Patients Undergoing WATCHMAN Left Atrial Appendage Closure Trial

Inova Health Care Services·observational·Posted Feb 2, 2017·Updated Mar 29, 2024

In Brief

An observational study evaluating WATCHMAN Left Atrial Appendage Closure for Left Atrial Appendage Closure and WATCHMAN Device Implantation. Completed, enrolled 35 participants across 1 site.

Detailed Summary

This study will evaluate thrombogenicity in patients undergoing left atrial appendage closure using the WATCHMAN device. Parameters of thrombosis and platelet function, as well as other bio-markers, will be measure before, during, and after WATCHMAN implantation at several follow up visits.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLeft Atrial Appendage Closure, WATCHMAN Device Implantation
CountriesUnited States
CollaboratorsBoston Scientific Corporation

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 2, 2017
Enrollment StartMar 1, 2017
Primary CompletionOct 15, 2019
Study CompletionDec 31, 2019
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 9.4 years ago

Interventions

WATCHMAN Left Atrial Appendage Closuredevice

WATCHMAN Left Atrial Appendage Closure